Malaria vaccine
The malaria vaccine is a significant advancement in public health. It aims to reduce the incidence of malaria, a disease that affects millions globally. The vaccine targets the Plasmodium parasite, which causes malaria. Its development marks a crucial step in combating this deadly disease. Effective vaccination could improve health outcomes in malaria-endemic regions, particularly in parts of India and Africa.
On 25 April 2026, the University of Oxford, through Oxford University Innovation, and the Serum Institute of India entered into a licence agreement for the development and manufacture...
April 29, 2026